Subash Jonnalagadda

  • 541 Citations
  • 13 h-Index
20022020
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research interests

Research Expertise: 
Organic & Medicinal Chemistry | Organoboron Chemistry | Alternate Energy Materials

Medicinal Chemistry: We have been developing novel aza- and bora-heterocyclic compounds and betulin-based natural product derivatives as anti-cancer agents. In collaboration with Rowan School of Osteopathic Medicine, we have also identified few Withaferin-serotonin conjugates as potential therapeutic options for the treatment of Alzheimers’ Disease.

Value Added Chemicals from Biomass: Recent efforts in this area have included the development of new protocols for the effective conversion of biomass derived cellulosic materials into chemicals such as hydroxymethyl furfural and furan dicarboxylic acid for applications as bio-based polymers.

Honors and Awards:
Rowan University Wall of Fame Teaching Award, 2013, 2016
Eli Lilly International Graduate Scholar, 2000-2005, Purdue University

Member of:
American Chemical Society (www.acs.org)

Education/Academic qualification

Doctor of Philosophy, doctorate

Bachelor of Science, Bachelor, Pondicherry University

Master of Science, Master, University of Hyderabad

Fingerprint Dive into the research topics where Subash Jonnalagadda is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Pyrrolidonecarboxylic Acid Chemical Compounds
Alkylation Chemical Compounds
Cytotoxicity Chemical Compounds
Boron Chemical Compounds
Cells Chemical Compounds
Lactams Chemical Compounds
Derivatives Chemical Compounds
Aldehydes Chemical Compounds

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2010 2020

Research Output 2002 2019

  • 541 Citations
  • 13 h-Index
  • 26 Article
  • 6 Chapter
  • 1 Comment/debate
  • 1 Review article

Strictinin, a novel ROR1-inhibitor, represses triple negative breast cancer survival and migration via modulation of PI3K/AKT/GSK3ß activity

Fultang, N., Illendula, A., Chen, B., Wu, C., Jonnalagadda, S., Baird, N., Klase, Z. & Peethambaran, B., May 1 2019, In : PloS one. 14, 5, e0217789.

Research output: Contribution to journalArticle

Open Access
Triple Negative Breast Neoplasms
phosphatidylinositol 3-kinase
Phosphatidylinositol 3-Kinases
breast neoplasms
Modulation
4 Citations (Scopus)

Benzoboroxoles: Synthesis and applications in medicinal chemistry

Mereddy, G. R., Chakradhar, A., Rutkoski, R. M. & Jonnalagadda, S., Jun 15 2018, In : Journal of Organometallic Chemistry. 865, p. 12-22 11 p.

Research output: Contribution to journalArticle

Pharmaceutical Chemistry
chemistry
synthesis
Organic Chemistry
Boronic Acids

Novel methodologies for the synthesis of biologically active Boron-based small molecules

Jonnalagadda, S., Penczuk, B. J., Twomey, K. M., Fishbein, S. H. & Suman, P., Aug 7 2018, Boron in Medicine. World Scientific Publishing Co. Pte Ltd, Vol. 4-4. p. 15-48 34 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Boron
Molecules
9 Citations (Scopus)
Molecular dynamics
DNA
Ligands
simulation
Intercalation
6 Citations (Scopus)

Recent Developments on the Synthesis and Applications of Betulin and Betulinic Acid Derivatives as Therapeutic Agents

Jonnalagadda, S., Suman, P., Morgan, D. C. & Seay, J. N., Jan 1 2017, Studies in Natural Products Chemistry. Elsevier B.V., p. 45-84 40 p. (Studies in Natural Products Chemistry; vol. 53).

Research output: Chapter in Book/Report/Conference proceedingChapter

Betula
Derivatives
Biological Products
Squalene
Therapeutics